Clinical Research John Marshall Oncology Unscripted: CROs and the Rising Costs of Clinical… Thomas Sullivan Oct 25, 2024 0 Clinical research organizations (CROs) have become an essential yet contentious part of modern medical research. Originating in…
Conflict of Interest NIH Scientific Integrity Policy 2024: Eliminates Detailed Sections on… Thomas Sullivan Oct 24, 2024 0 The National Institutes of Health (NIH) has released a comprehensive update to its Scientific Integrity Policy, marking a…
CMS CMS Releases Prices for Inflation Reduction Act Drug Price Negotiation… Thomas Sullivan Oct 23, 2024 0 On Thursday, August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) released the prices for the first 10…
HIPAA HHS OCR Levies $115,200 CMP Against American Medical Response for HIPAA… Thomas Sullivan Oct 22, 2024 0 Recently, the United States Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced a $115,200 civil…
Drug Prices The Inflation Reduction Act (IRA) and Its Broader Impact on Innovation,… Thomas Sullivan Oct 21, 2024 0 On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects…
CMS Humana Reaches $90 Million Settlement in First of Its Kind False Claims Act… Thomas Sullivan Oct 18, 2024 0 Humana recently reached a $90 million settlement with the United States to resolve allegations that Humana submitted fraudulent…
DOJ Gentiva Reaches $19.4 Million False Claims Act Settlement Thomas Sullivan Oct 17, 2024 0 Gentiva – formerly known as Kindred at Home – reached a $19.4 million settlement with the United States, resolving allegations…
FDA OPDP Sends Untitled Letter to Kaleo for Influencer Social Media Post Thomas Sullivan Oct 16, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an Untitled Letter to…
DOJ DOJ Announces Corporate Whistleblower Award Pilot Program Thomas Sullivan Oct 15, 2024 0 The United States Department of Justice (DOJ) started a Corporate Whistleblower Awards Pilot Program to help uncover and prosecute…
FDA Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating… Thomas Sullivan Oct 14, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter…